Peptide-based body lotions and oils combine two separate aspects: the form of the cosmetic product and the declaration regarding the presence of a specific ingredient. The form of the product describes its overall composition, consistency, method of application, or sensory properties, whereas the information about peptides indicates the presence of a component that is attributed with specific potential effects on the skin.
However, none of these elements alone does not prove that the finished product causes measurable skin tightening, delivers a peptide to the appropriate layer of the skin, or causes permanent structural changes.
The product may contain a peptide, but its presence alone does not yet tell what happens to it after application. Similarly, a balm can improve the softness or hydration of the skin thanks to a whole system of moisturizing ingredients, without showing that the peptide is responsible for the observed effect.
Studies of body care products are most reliable when scientists evaluate the actual, ready-to-use product on that part of the body for which the claimed action applies.
For example, a study conducted on the skin of the arms can directly support the claim regarding this area, provided that the formulation, the population studied, and the conditions of use are sufficiently similar. However, a study of a face cream, an experiment on isolated cells, or an oral study of ingested collagen address other interventions and answer different scientific questions.
This distinction is important because terms such as moisturizing, smoothing, firming, tightening the skin, improving elasticity, or supporting collagen are often presented together, even though they do not describe the same end point.
In this article, we look at the differences between balms, creams, and oils, the importance of formulations and the application site, the difference between hydration and firming, and what selected studies involving humans actually show. Importantly, the improvements observed after applying the entire formulation should not be automatically interpreted as evidence that the peptide ingredient itself was responsible for them.
Balms, creams and body oils
The names of product formats describe partially overlapping categories
Terms such as body lotion, body cream or body oil are useful, but they do not define rigid scientific categories.
Body lotions and creams are usually emulsions. In simple terms, they are formulation systems that combine the components of the aqueous and oil phases in a structure that allows them to be properly distributed in the finished product.
Balms are often designed to be easier to apply and have a lighter, more fluid consistency. Creams, on the other hand, often have a richer and denser texture.
Such a distinction is useful for the consumer, but it does not constitute a strict chemical rule.
Two products sold as balms can differ significantly in composition. Similarly, one cream may, in terms of its formulation, more closely resemble a specific balm than another product also sold as a cream.
A similar caution requires the term „oil”.
Body oil can be a product that is mostly or completely water-free. In other cases, the marketing name may emphasize the oily consistency, even though the finished formulation uses a more complex system for delivering the ingredients.
A simple mixture of oils and an emulsion containing the oil phase do not therefore have to be equivalent products.
From a scientific point of view, the actual composition and structure of the formulations are more important than the general category listed on the front of the packaging.
This is especially important for peptides.
Individual peptides have different physicochemical properties. The molecule size, charge, solubility, chemical modifications, and interactions with the other components of the formulation can influence their behavior.
Therefore, a product containing peptides cannot be reliably evaluated solely on the basis of whether it has a watery, creamy, or oily consistency.
The humidification system can operate independently of the peptides
Ready-to-use body moisturizers usually contain several groups of ingredients that can affect the appearance and sensations of the skin regardless of the presence of the peptide.
The formulation may contain water-binding and moisturizing components for the superficial layers of the skin, emollients to improve smoothness and sensory sensations, and ingredients to help limit water loss.
These functions can coexist with the presence of peptides.
Therefore, if people using a peptide-based balm see improvements in skin hydration, softness, or comfort, this does not automatically mean that the peptide was responsible for these effects.
The formulation database itself forms part of the intervention being studied.
It should not be treated as an inactive carrier whose sole function is to deliver the designated peptide component.
A well-developed moisturizing product can produce significant cosmetic effects thanks to the interaction of many ingredients.
This is important for the way results are described.
If the controlled study shows an improvement in hydration after using a balm containing peptides, a justified conclusion may be:
„The formulation studied improved skin hydration under the test conditions.”
It is something different than saying:
„The peptide resulted in an improvement in hydration.”
The second claim requires evidence to separate the effect of the peptide from the effect of the other components of the formulation.
This does not mean that studies of finished products are weak or insignificant. It merely means that the effectiveness of the product as a whole and attributing the action to a single component are two different research questions.
Peptide oil is not automatically equivalent to a cream
In order for the peptide to play an important role in the finished cosmetic formulation, several issues must be taken into account.
The peptide should be appropriately incorporated into the formulation, maintain sufficient stability over the appropriate storage and use period, and remain available under the conditions of use in a manner consistent with the declared activity.
Simply listing a peptide in the list of ingredients does not resolve these issues.
Preclinical studies regarding GHK-Cu showed that this complex exhibited strong affinity for the aquatic environment and stable behavior depending on the conditions.[1]
This is a good example showing why it should not be assumed automatically that peptides behave like typical oil-soluble components.
However, on this basis, one cannot draw the opposite, equally general conclusion that oils containing peptides are impossible to develop or by definition ineffective.
Peptides differ from each other.
Chemical modifications can alter their properties. Delivery systems can also utilize carriers, emulsifiers, dispersed phases, or other components that affect the way the peptide is incorporated into the formulation.
Therefore, body oil with peptides should be evaluated based on its actual formulation structure, and not just on the marketing name itself.
It is worth distinguishing between a peptide dissolved in the appropriate phase, a peptide material dispersed in a formulation, a peptide incorporated into a carrier system, and a simple oil mixture containing a component whose behavior has not been characterized.
The same principle applies to stability.
Demonstrating that the peptide remains chemically identifiable in the formulation is valuable information, but the result of the stability study is not equivalent to proof of penetration through the skin or clinical activity.
We also discuss in the article about peptide behavior in more detail why it depends on specific conditions and formulations. Storage of peptides.
The structure of the formulation can affect the delivery of the peptide
The carrier surrounding the peptide can affect its behavior after application.
In an experimental study involving acetyl hexapeptide-8, various emulsion systems were compared and it was found that differences in their internal structure affected the delivery of the peptide to the porcine skin. [2]
This is an important observation because it shows that the formulation is not merely a passive backdrop.
The wording itself is part of a scientific explanation.
The study did not, however, show a universal hierarchy in which oils, creams or balms would always be better than the other formats.
A more justified conclusion is that delivery may depend on the interaction of a specific peptide with a specific formulation system.
A product containing the same peptide as the previously studied cream may therefore differ significantly in terms of release, distribution, and interaction with the skin.
Similarly, increasing the density, richness, or content of the oil phase does not automatically mean that the peptide is delivered better.
This requires direct research.
| Product description | Useful question | Evidence needed |
|---|---|---|
| Body balm with peptides | What improves the finished balm as a whole? | Testing the finished product on the appropriate body area |
| Body cream with peptides | Does the peptide add an additional effect beyond the action of the base? | Appropriate comparison of matched formulations |
| Body oil with peptides | How was the peptide introduced and maintained in the formulation? | Data regarding identity, compliance and stability |
| Firming cosmetic | What mechanical or visual parameter has changed? | Defined instrumental measurements or clinical assessments |
| A product with long-lasting effect | How long does the measured effect last? | Observation corresponding to the declared period of operation |
The table shows why the term „contains peptides” alone does not answer all the questions about the product for the body. The composition, the stability of the formulation, the delivery of ingredients, the action of the finished product, and the durability of the effect constitute separate levels of evidence.
Formulation and application site
Results regarding the face and body cannot be considered equivalent
A clinical study of the facial skin provides information about the specific formulation, the population, the application site, the exposure schedule, and the evaluated outcome.
Transferring such a result from one part of the face to another part of the body means a change in context.
Shoulders, thighs, abdomen, forearms and hands are not simply interchangeable research surfaces. Even if the same peptide is used, differences in formulation, product quantity, practical method of use, and endpoint examined can affect interpretation.
In a controlled study of a moisturizing face cream containing palmitoyl pentapeptide, improvement in wrinkles was noted compared to a correspondingly matched moisturizing base.[3]
This is evidence related to the intervention being studied on the skin of the face.
It does not independently prove that another product containing this peptide tightens the thighs, reduces the stiffness of the arms, or improves the appearance of stretch marks.
Studies involving the face can serve as a scientific basis for conducting similar studies on other areas of the body.
However, the biological reliability of the mechanism is not the same as its clinical confirmation.
The missing element must be investigated, not assumed.
We discuss more about interpreting the results regarding skin tightening, elasticity, and firmness in the article about peptides that firm the skin.
Different areas of the body require different endpoints.
The broad term „skin quality” can encompass several distinct results.
The problem may be dryness, roughness, parchment-like appearance of the skin, loss of elasticity, stiffness, uneven texture, or another characteristic.
They should not be combined into one undefined parameter.
The product can improve one of these elements without affecting the others.
A study on the roughness of the arm skin does not automatically answer the question of whether the product changes the appearance of cellulite on the thighs.
Similarly, a measurement taken at a specific point on the forearm does not prove that the entire body has been toned.
The photo of a single selected area also does not show that all application locations changed to the same extent.
Therefore, precise definition of the area under study increases the evidentiary value of the results.
Researchers should provide the location of the measurements, the method of standardizing their placement, and the characteristics of the participants relevant to the declared study.
A narrowly targeted study can still provide valuable evidence.
However, his conclusions should also remain appropriately narrow.
The amount of product used and the area of application influence the interpretation
Body products raise additional questions regarding exposure, as they are often applied to much larger and more diverse surfaces than cosmetics intended for small areas of the face.
The total amount of peptide in the package does not indicate how much of it is per unit area of skin.
The application technique, total surface area, frequency of use, and protocol compliance may affect actual exposure.
These variables are therefore important in clinical studies.
However, this does not mean that using a larger amount of the product must produce a greater effect.
Comparing concentrations or quantities can be misleading if different formulations, application surfaces, or usage conditions are used.
A well-described study should present the intervention in such detail that it is possible to understand what the participants actually used and whether the exposure corresponds to the claimed method of use of the product.
It is crucial that the intervention under study is consistent with the intervention to which the declared action applies.
The result obtained in a small, standardized measurement area should not be presented as proof of unlimited action on the entire body.
Mechanical and environmental factors can interfere with the results
Factors unrelated to the mechanism of action of the peptide can affect skin measurements.
Recent skin cleansing, residues of other cosmetics, room temperature and humidity, and the participant's position can affect some instrumental or visual measurements.
Changes in the rest of the care can also make interpretation difficult.
Changes in body weight can be particularly important in body appearance studies, as they can affect the silhouette and the appearance of the skin regardless of the cosmetic product being examined.
Therefore, scientists are trying to standardize the essential conditions.
A split-body design can be useful, where the opposite sides of the body of the same person receive different interventions. This limits some of the variability resulting from differences between participants.
Such a project still requires the appropriate allocation of interventions, comparable application sites, and statistical analysis that takes into account the paired nature of the measurements.
No research project eliminates all sources of uncertainty.
Controlling the factors that interfere with the results does not turn a small cosmetic study into universal proof.
It should make the comparison easier to interpret.
Moisture and the claimed firming effect
Moisture content, firmness and elasticity describe various properties
Moisture content, firmness, and elasticity are related to the appearance and physical behavior of the skin, but they do not describe the same property.
Moisturizing primarily concerns properties related to the water content in the superficial layers of the skin and can be evaluated using appropriate instrumental methods.
Stiffness usually refers to the resistance of the skin to deformation under specific measurement conditions.
Flexibility describes the aspects of the skin returning to its previous shape after deformation.
On the other hand, the feeling that the skin is more tense is a subjective sensory observation, rather than a direct measurement of a specific mechanical property.
These terms should therefore not be used interchangeably.
Even in instrumental studies, different parameters can represent different elements of the mechanical behavior of the skin.
Improving one parameter does not automatically mean that every aspect of firmness or elasticity is improved.
Moisture can also affect the appearance and sensations of the skin.
Therefore, a smoother appearance or a favorable change in the mechanical measurement are not a standalone proof of the formation of new collagen.
The claim regarding the structural mechanism requires additional evidence.
Immediate smoothing and lasting change require other proofs
Body lotion can make the skin look smoother shortly after application thanks to the entire system of moisturizing, emollient or film-forming ingredients.
This could be a real cosmetic effect.
However, the immediate effect and the lasting structural change are not the same thing.
The measurement was performed shortly after application, assessing the skin at a time when the product or its direct effects may still be affecting the result.
The measurement after several weeks of regular use answers another question.
Another question is whether the observed change persists after the product is discontinued.
These timeframes must be presented separately.
The term „long-term tightening” is difficult to interpret if the study does not specify when the final measurement was performed and whether the participants continued to use the product.
The temporary effect should not be dismissed just because it is temporary.
Cosmetics can, according to their intended purpose, provide a temporary improvement in appearance or sensory sensations.
The problem arises when the immediate superficial effect is presented as a lasting tissue reconstruction without adequate evidence.
Improving the appearance of the skin is not a reconstruction of the body contour
Improvements in smoothness, hydration, or firmness measurements do not indicate a loss of fat tissue, an increase in muscle mass, or the removal of significant excess skin.
These are other anatomical structures and other endpoints.
Similarly, improvements in the scale of cellulite assessment should not be presented as weight loss.
Moisturizing cosmetics cannot also be considered an equivalent of a procedure just because both interventions are described in terms such as „tightening” or „tightening.”.
The endpoint, the magnitude of the change, the duration of its retention, and the comparator used must be taken into account.
Special caution is required regarding claims regarding skin after significant weight loss.
The study of people with mild age-related atrophy does not necessarily reflect the situation of people with significant excess skin after a large weight loss.
The studied population therefore sets an important limit for interpretation.
Biomarkers do not indicate rejuvenation of the entire organism
Laboratory studies can analyze gene expression, extracellular matrix proteins, cell behavior, and other molecular results.
Such observations help develop hypotheses and investigate possible mechanisms.
However, they do not prove on their own that a person using a body lotion will experience a clinically noticeable benefit.
The same principle applies to circulating biomarkers in the blood.
In a short cosmetic study, changes in certain biological markers can be observed, but this does not automatically mean a reduction in the risk of diseases, a slowing down of the aging process of the entire organism, or an extension of life.
A biomarker is not synonymous with a clinically relevant health outcome.
His interpretation also depends on the comparator, the number of analyses performed, statistical methods, and possible alternative factors influencing the result.
Therefore, a scientifically rigorous analysis of peptide-based balms should not translate exploratory results regarding biomarkers into claims about „aging the entire body.”.
The most justified interpretation remains related to what was actually measured.
Evidence regarding the finished formulation
Study of a body balm containing a peptide
In a 12-week randomized, double-blind pilot study, 60 women aged 60–90 years participated. The formulation containing OS-01 was compared with another commercially available moisturizing product. 52 people completed the study. [4]
The difference between the groups regarding skin hydration of the arm spoke in favor of the tested formulation.
However, the corresponding comparison on the forearm did not reach the conventional level of statistical significance. [4]
The difference between the measurement sites shows why the results should be attributed to the actually evaluated location, rather than being presented as a universal improvement in the skin of the entire body.
The study also compared two complete products.
The identical formulation containing OS-01 was not compared with the same formulation from which OS-01 was removed only.
The study therefore provides evidence at the product level, but does not allow one to independently determine which part of the observed difference was specifically due to the presence of the peptide.
Information regarding tolerance is also important.
Three participants from the group using the product under investigation withdrew due to moderate skin reactions considered potentially related to the test product or the cleansing agent supplied.[4]
This does not invalidate the other results, but it limits the possibility of formulating statements about universal tolerance.
The study also does not show that any body product with peptides improves firmness or that using such a formulation extends the period of healthy life.
Controlled studies of firming products provide useful indirect evidence
Other controlled studies of body moisturizers show how to assess claims regarding firmness.
In a separate, 12-week, randomized, double-blind split-body study involving 40 women, a firming moisturizing product was compared with a placebo on the skin of the arms. [5]
The researchers described an improvement in clinical and instrumental evaluations and applied an ultrasound examination [5].
This is important because it shows an organized approach to evaluating the finished product on a specific body area.
However, the abstract itself does not show that the peptides were responsible for the observed changes.
The study should therefore be interpreted as evidence regarding the finished firming product, and not automatically as evidence of the effectiveness of the isolated peptide.
In another study controlled by the carrier, 54 women with problems of skin firmness in the arms and cellulite on the thighs participated.[6]
The study combined the clinical evaluation of the product in humans with separate ex vivo experiments and studies of skin models.
The individual parts provide different types of evidence.
Laboratory experiments can help investigate possible mechanisms, while clinical trials evaluate the results under conditions of human use of the product.
However, the results obtained ex vivo should not be described as if the biopsies taken from the participants in the clinical trial showed exactly the same structural changes.
Both studies are useful examples of research on body products.
None of them confirms the effectiveness of any balm, cream, or oil containing peptides.
Protocols and planned studies are not the results of completed efficacy studies
Not every record in a scientific database describes an completed study.
One publication presented a controlled study plan for a body lotion in mild atopic dermatitis, specifying the planned comparator and clinical results, but without presenting the results of the completed efficacy study.[7]
The protocol can provide valuable information about how the researchers intend to answer the given question.
However, it does not prove that the intervention ultimately proved to be effective.
This distinction is particularly important when counting publications or assessing the apparent size of the evidence base.
The search result can lead to a research protocol, a narrative review, a laboratory experiment, an observational study, or an completed controlled trial involving human participants.
These publications do not provide equivalent levels of clinical evidence.
Studies concerning a specific disease should not be automatically used as evidence of a cosmetic firming effect.
Evidence regarding a specific condition and its defined endpoints remains evidence regarding that question until additional studies justify a broader interpretation.
What should a convincing product review include?
A useful product-body study should clearly specify the exact formulation being studied, the population of participants, the application sites, the comparator, the duration, and the primary endpoint.
In appropriate cases, it should also describe randomization and blinding.
Information about resignations, adverse effects, magnitude of the effect, and statistical uncertainty help to better understand the result.
If the scientific question concerns the individual contribution of a peptide, comparing possibly similar formulations with and without the peptide provides more information than a comparison of two clearly different commercial moisturizing products.
Analytical evidence can also be significant if the declaration depends on the identity or content of the peptide.
Methods developed for the determination of palmitoylated peptides in cosmetic products show a difference between analytical confirmation of peptide presence and its acceptance solely based on marketing information. [8]
However, confirmed content is only one level of evidence.
It does not prove independently the delivery of the peptide to the skin or the effectiveness of the product.
The repeatability of the results can further increase confidence in the conclusions, especially if the first study was small.
Commercial funding or the authors' connections to industry do not automatically invalidate the study, but transparent reporting allows these issues to be considered together with randomization, control, blinding, sample size, and other elements of methodological quality.
The result should be interpreted at the level at which it was actually examined.
The statistical significance and the practical importance of the result are related but separate issues.
Statistically significant difference in instrumental measurement may be numerically small.
In turn, a spectacular photo may depend on the position of the body, the lighting, the camera settings, or the choice of a specific photograph.
The participants' satisfaction, the researcher's assessment, photographs, and instrumental measurements therefore provide different types of information.
A good study explains the relationships between these results, rather than presenting them all as equivalent evidence.
When assessing the claimed firming effect, four questions are particularly useful:
What has changed? Compared to what? In what area of the body? How long has the change been observed?
These questions help maintain the interpretation within the limits of the experiment conducted.
If the answers to them are unclear, even a well-known or scientifically interesting name for a peptide will not replace the missing context.
The available evidence justifies the study of specific products.
They do not prove that every peptide-based balm provides significant lifting effects, that oil products replicate the results achieved with creams, nor that studies of peptides applied to the face automatically predict the effects of body products.
Frequently asked questions
1. Can the results of facial product testing be transferred to body products?
Studies of the face can provide scientific justification for the study of similar body products, but do not directly confirm the effect of another formulation applied to another anatomical area. A controlled study of a facial moisturizing product containing palmitoyl pentapeptide evaluated facial wrinkles under specific conditions. [3] It does not independently demonstrate the lifting of the arms, thighs, or abdomen. The composition of the product, the population studied, the method of exposure, the site of application, and the endpoint are important. A declaration regarding a body product therefore requires evidence that adequately addresses these differences.
2. Does the oil contain the same type of peptide formulation as the cream?
Not necessarily. A simple anhydrous oil blend, an emulsion rich in the oil phase, and a peptide formulation using a carrier system can be completely different systems. The peptides themselves also differ significantly in their physicochemical properties. Pre-formulation studies of GHK-Cu showed, for example, a strong affinity of this complex for the aquatic environment under the tested conditions. [1] This does not mean that every peptide is compatible with every oil product. It does, however, show why equivalence cannot be assumed based on the product name alone. The actual composition, the way the peptide is introduced, and compatibility and stability require evaluation specific to the given formulation.
3. Does better hydration mean firmer skin?
No. Hydration and mechanical firmness are separate endpoints. The study can assess both parameters, but increasing superficial hydration does not automatically lead to an equivalent improvement in resilience to deformation or another firmness parameter. Various instrumental and clinical methods can be used in body product studies depending on the question being examined. [5] Hydration can also make the skin appear smoother and more pleasant to the touch, which can affect the subjective perception of firmness. The conclusion should therefore indicate the parameter that has actually changed.
4. Does the feeling of greater firmness mean the formation of new collagen?
No. The subjective perception of more taut or firm skin is not a direct measure of collagen synthesis. Hydration, the product layer on the surface, and the evaluation conditions can influence sensory perceptions. Structural claims require additional evidence to support the proposed change in tissue. Laboratory and ex vivo studies can provide mechanistic information, but they should be distinguished from observations in people using a ready-made product. [6] A perceived greater firmness may be a valuable cosmetic effect without evidence that it was caused by the formation of new collagen.
5. Can a peptide-based serum remove excess skin after a significant weight loss?
The studies discussed do not show such an effect. Improving minor sagging, texture, or a specific cosmetic parameter is fundamentally different from removing significant excess skin after significant weight loss. The results of controlled tightening studies conducted on selected participants cannot be automatically generalized to every type and degree of skin sagging. [5] The anatomical problem and the measured endpoint must correspond to the formulated declaration.
6. Can the results regarding the thighs and arms be treated interchangeably?
No. The arm and shoulder are different anatomical areas, and tests can also assess various problems in them. One test may focus on arm stiffness, while another on cellulite or the texture of the arm skin. Even if both areas are assessed in the same test, the results should be presented and interpreted separately. [6] The result for one area may serve as the basis for further testing, but it does not replace such testing.
7. Does body oil with peptides have to penetrate the skin better?
No. The oily or rich consistency is not a measure of peptide penetration. Experimental studies with acetyl hexapeptide-8 showed that the internal structure of different emulsion systems influenced the delivery of peptide to the skin of pigs.[2] This demonstrates the importance of formulation, but does not prove that any oil is better or worse than any balm or cream. A credible claim regarding penetration requires testing a specific peptide in a real formulation.
8. Is it possible to analytically test the peptide content in the balm?
Yes, if an appropriate analytical method has been developed and validated for a given peptide and formulation. Studies using LC-MS/MS show that palmitoylated peptides can be detected in cosmetics. [8] Such tests can provide important information about the identity and content of the ingredient. However, confirmation of the presence of a peptide does not tell how much of it reaches the skin, where it is located after application, or whether it causes a clinical effect. Analytical verification is therefore an important element of evidence, but it does not constitute full confirmation of efficacy.
9. Does the term „clinically tested” mean that the result was due to a peptide?
No. A clinical study may involve a complete product containing a peptide, without determining whether the peptide itself was responsible for the result. In the study of the product for the body with OS-01, the test formulation was compared with another moisturizing product, and not with an identical formulation that differed only in the presence of OS-01. [4] The result therefore concerns the compared finished products. The term „clinically tested” alone does not inform about the comparator, the endpoint, the magnitude of the effect, or the extent to which the result can be attributed to a specific component.
10. Are the before and after photos sufficient as proof of the lifting effect?
No. Photographs can be valuable visual documentation, but lighting, camera position, body posture, distance, and the choice of shots can influence the appearance. Standardized photographs are more informative when accompanied by controlled comparisons, uniform conditions of photography, blind evaluation, or appropriate instrumental measurements.[5] The photographs themselves do not prove a lasting structural change or that the observed difference was due to the peptide.
11. Do the results observed during product use indicate a lasting effect?
No. The result measured during regular use of the product shows the effect during the ongoing exposure. Establishing the durability requires additional observation after discontinuing use. A 12-week study may therefore show what happened during that period or at its end, but it does not automatically prove that the effect will persist for another year or permanently. Statements regarding durability should correspond to the actual observation period.
12. Does the change in the biomarker of aging mean an extension of life?
No. A change in the exploratory biomarker does not indicate an increase in survival, a reduction in the risk of diseases, or an extension of life in good health. In a pilot study of a body formulation containing a peptide, biological markers were evaluated over a relatively short period, but this was not a study concerning lifespan. [4] Biomarker studies can be scientifically interesting and generate hypotheses, but the result should remain described as a biomarker result until further studies convincingly link it to significant clinical results.
13. Does the clinical trial protocol prove that the balm works?
No. The protocol describes the way in which researchers intend to conduct the study. It may specify the criteria for participation, groups, endpoints, duration, and statistical methods, but it does not contain the results of the completed efficacy study. The published protocol for the balm used in mild atopic dermatitis presented the study plan, not the final efficacy analysis. [7] Therefore, before drawing conclusions, it is necessary to check whether the results have been published later.
14. Are body products with peptides automatically gentle on the skin?
No. Tolerance depends on the entire formulation, exposure conditions, and the individual characteristics of the user, not on the information itself about the presence of the peptide. In a study of a body product containing OS-01, cases of skin reactions potentially related to the test product or the cleansing agent were reported. [4] This shows why reporting adverse reactions is important even when the mean test results are favorable.
15. Does a higher concentration of the peptide have to mean a better product?
No. Higher concentration does not guarantee better stability, release, penetration, tolerance, or clinical efficacy. Formulation studies show that the surrounding carrier peptide can influence its behavior and delivery.[2] A reliable comparison of the concentration-dependence would require controlling other important formulation and application variables and measuring a specific outcome. Without such evidence, a higher percentage of peptide is primarily an indication of composition rather than evidence of better performance.
16. Do the results regarding collagen in cell studies confirm the effect of the body balm?
Cellular studies may support the hypothesis regarding the mechanism, but do not independently demonstrate the clinical effect in people using the balm. Cell cultures and ex vivo tissues do not replicate all aspects of applying a full cosmetic formulation to live human skin. Some studies of body products combine laboratory experiments with clinical assessments, and both levels of evidence can complement each other.[6] However, the collagen-related responses observed in cells should not be presented as if a structural change identical to that directly demonstrated in the participants’ skin was observed.
17. What should a credible statement regarding body skin tightening specify?
A credible claim should indicate a ready-made formulation that has been tested, the appropriate body area, characteristics of the studied population, a comparator, the measured endpoint, and the duration of the observation. It should also distinguish the effect of the entire product from evidence that allows attributing that effect to a specific peptide. Information about tolerability, participant attrition, and statistical uncertainty should also remain visible. Controlled studies of body moisturizers show how such questions can be analyzed.[5] The most credible claim remains within the study’s boundaries rather than extending the local or short-term result to every body area, every person, and every formulation.
Summary
Balsams, creams, and body oils containing peptides should not be considered equivalent interventions simply because they all contain the term „peptides.”.
The formulation surrounding the peptide has scientific significance.
Balms, creams, emulsions, and oil products can differ in composition, internal structure, stability, and the way ingredients become available after application. Experimental studies show that the formulation structure can influence the delivery of a peptide, whereas pre-formulation studies indicate why the properties of a specific peptide should be considered. [1][2]
The moisturizing base itself can also have effects regardless of the designated peptide component.
Moisture, softness, smoother appearance, and improved comfort can result from the action of the entire moisturizing system. Therefore, the fact that a product containing peptides works favorably does not automatically mean that the peptide was the responsible factor for the result.
Distinguishing between the action of the finished product and the attribution of the effect to a single component is crucial for the correct interpretation of the evidence.
Another important boundary is the location of the application.
Facial skin studies can provide biological or formulation context, but they do not automatically demonstrate effects on the arms, thighs, abdomen, or entire body. Similarly, a result obtained in one place should not be transferred to all other areas without additional data.
The final point is equally important.
Moisture, a sense of firmness, mechanical firmness, elasticity, skin smoothness, and structural tissue remodeling are different results. The beneficial change in one of them should not be presented as proof of improvement in all the others.
Improvements in cosmetic appearance should not be interpreted as a loss of fat tissue, an increase in muscle mass, the removal of significant excess skin, or the rejuvenation of the entire body.
Selected controlled studies involving humans show that body moisturizers can be evaluated using relevant clinical and instrumental endpoints.[4][5][6] These results justify further studies of specific products.
However, they do not confirm the universal effect of peptides.
They also do not prove that every peptide-based moisturizer firms the skin, that peptide-based oil replicates the results achieved with a cream, that studies of facial products predict the effects of body products, or that short-term cosmetic effects mean lasting skin firmness.
Therefore, a good statement regarding a body product should answer several related questions: what exactly formulation has been tested? On which area of the body? In which population? Compared to what? What endpoint has changed? How large was this change? How long was it observed? Was the individual contribution of the peptide actually isolated?
Keeping these questions at the center of interpretation actually allows us to present positive results without expanding them beyond what the studies actually showed.
Disclaimer
This article is purely educational and scientifically informative. It discusses cosmetic formulations, peptide ingredients, body moisturizers, and the interpretation of studies regarding skin care. It is not intended to diagnose skin diseases, nor to provide therapeutic recommendations or recommendations for the use of a specific cosmetic product, cream, balm, oil, or peptide.
Results of studies regarding one formulation should not be automatically considered as evidence of the efficacy, tolerance or biological activity of another product. Differences in the type of peptide, its concentration, chemical modification, formulation system, stability, application site, amount of product used, time of use, and other components may affect the possibility of transfer of results.
Similarly, evidence derived from studies of facial products, cell experiments, ex vivo tissue studies, animal models, or laboratory analyses should not be automatically interpreted as confirmation of the equivalent effect of the product on the body when applied to live human skin.
Cosmetic improvements in hydration, smoothness, firmness parameters or subjective perception of tension should not be interpreted as evidence of loss of fat tissue, increase in muscle mass, removal of significant excess skin, rejuvenation of the entire body, or prolongation of life, unless such results have been directly examined.
Tolerance may vary between individuals and products. In the case of persistent skin irritation, a dermatological disease, significant skin changes, or significant skin laxity, an appropriate individual consultation with a properly qualified specialist may be necessary.
References
- Badenhorst, T., Svirskis, D., & Wu, Z. (2016). Physicochemical characterization of native glycyl-l-histidyl-l-lysine tripeptide for wound healing and anti-aging: A preformulation study for dermal delivery. Pharmaceutical Development and Technology, 21(2), 152–160. https://doi.org/10.3109/10837450.2014.979944
- Hoppel, M., Reznicek, G., Kählig, H., Kotisch, H., Resch, G. P., & Valenta, C. (2015). Topical delivery of acetyl hexapeptide-8 from different emulsions: Influence of emulsion composition and internal structure. European Journal of Pharmaceutical Sciences, 68, 27–35. https://doi.org/10.1016/j.ejps.2014.12.006
- Robinson, L. R., Fitzgerald, N. C., Doughty, D. G., Dawes, N. C., Berge, C. A., & Bissett, D. L. (2005). Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin. International Journal of Cosmetic Science, 27(3), 155–160. https://doi.org/10.1111/j.1467-2494.2005.00261.x
- Zonari, A., Brace, L. E., Buhrer, L. B., Harder, N. H. O., Harker, C., Aronson, A. B., Tse, C. N., Oliveira, C. R., Boroni, M., & Carvalho, J. L. (2025). OS-01 peptide topical formulation improves skin barrier function and reduces systemic inflammation markers: A pilot 12-week clinical trial. Journal of Cosmetic Dermatology, 24(4), Article e70169. https://doi.org/10.1111/jocd.70169
- Kavali, C. M., Nguyen, T. Q., Zahr, A. S., Jiang, L. I., & Kononov, T. (2021). A randomized, double-blind, split-body, placebo-controlled clinical study to evaluate the efficacy and tolerability of a topical body firming moisturizer for upper arm rejuvenation. Aesthetic Surgery Journal, 41(6), NP472–NP483. https://doi.org/10.1093/asj/sjaa134
- Makino, E. T., Jiang, L. I., Acevedo, S. F., Nguyen, A., Cheng, T., Kadoya, K., & Mehta, R. C. (2023). Restoration of aging body skin: Evidence-based development of a topical formulation for improving body skin quality. Journal of Drugs in Dermatology, 22(9), 887–897. https://doi.org/10.36849/JDD.7292
- Duan, Z., Ding, Y., & Wang, R. (2025). Efficacy and safety of Haidebao body lotion in patients with mild atopic dermatitis: Protocol for a multicenter, double-blind, randomized, placebo-controlled trial. JMIR Research Protocols, 14, Article e71255. https://doi.org/10.2196/71255
- Chirita, R. I., Chaimbault, P., Archambault, J. C., Robert, I., & Elfakir, C. (2009). Development of a LC-MS/MS method to monitor palmitoyl peptides content in anti-wrinkle cosmetics. Analytica Chimica Acta, 641(1-2), 95–100. https://doi.org/10.1016/j.aca.2009.03.015